NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
| Weiss Ratings | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.40 | |||
| Price History | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -93.32% | |||
| 30-Day Total Return | -93.32% | |||
| 60-Day Total Return | -86.43% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | -86.43% | |||
| 1-Year Total Return | -81.00% | |||
| 2-Year Total Return | -90.62% | |||
| 3-Year Total Return | -83.48% | |||
| 5-Year Total Return | -99.45% | |||
| 52-Week High % Change | -96.20% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 23, 2024 | |||
| 52-Week High Price (Date) | Jan 21, 2025 | |||
| Valuation | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 475.65K | |||
| Enterprise Value | 495.03K | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -25.48% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.02 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -2.87 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 10.28M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 720 845 1483 | |||
| Address | 1090 West Georgia Street Vancouver, BC V6E 3V7 | |||
| Website | www.jphres.org/nanospherehealth/ | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -541.47% | |||
| Return on Equity | -- | |||
| Income Statement | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -181.50K | |||
| Net Income (TTM) | -199.00K | |||
| Net Income Avl. to Common (TTM) | -199.00K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -0.48% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -2.50% | |||
| Balance Sheet | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 22.90K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.68M | |||
| Current Ratio (Q) | 0.013 | |||
| Book Value Per Share (Q) | -$0.16 | |||
| Total Assets (Q) | 22.90K | |||
| Total Current Liabilities (Q) | 1.71M | |||
| Total Debt (Q) | 32.00K | |||
| Total Liabilities (Q) | 1.71M | |||
| Total Common Equity (Q) | -1.68M | |||
| Cash Flow | NSHSF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 30.80K | |||
| Net Change in Cash (TTM) | 400.00 | |||
| Levered Free Cash Flow (TTM) | 56.30K | |||
| Cash from Operations (TTM) | -31.00K | |||
